BrightSpring Health Services (NASDAQ:BTSG) Stock Price Expected to Rise, UBS Group Analyst Says

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) had its target price upped by stock analysts at UBS Group from $22.00 to $30.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's target price suggests a potential upside of 27.12% from the stock's previous close.

Several other research firms also recently issued reports on BTSG. Wells Fargo & Company lifted their price target on BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, November 27th. BTIG Research upped their price target on BrightSpring Health Services from $15.00 to $20.00 and gave the stock a "buy" rating in a research report on Thursday, October 3rd. Morgan Stanley raised their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 17th. Mizuho boosted their price objective on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. Finally, KeyCorp began coverage on shares of BrightSpring Health Services in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.42.

BrightSpring Health Services Trading Down 2.6 %

BTSG stock traded down $0.64 during trading on Wednesday, hitting $23.60. The company had a trading volume of 1,939,040 shares, compared to its average volume of 1,511,143. The stock has a market cap of $4.11 billion and a price-to-earnings ratio of -90.77. BrightSpring Health Services has a 12 month low of $7.85 and a 12 month high of $24.82. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. The firm has a 50-day moving average price of $18.82 and a 200-day moving average price of $15.99.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.72 billion. BrightSpring Health Services's revenue for the quarter was up 28.8% on a year-over-year basis. As a group, analysts predict that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. R Squared Ltd bought a new position in BrightSpring Health Services in the 4th quarter valued at about $74,000. Intech Investment Management LLC bought a new position in shares of BrightSpring Health Services during the third quarter worth approximately $159,000. nVerses Capital LLC lifted its holdings in BrightSpring Health Services by 195.8% during the 3rd quarter. nVerses Capital LLC now owns 14,200 shares of the company's stock worth $208,000 after purchasing an additional 9,400 shares during the last quarter. American Century Companies Inc. bought a new stake in BrightSpring Health Services in the 2nd quarter valued at $216,000. Finally, BNP Paribas Financial Markets grew its holdings in BrightSpring Health Services by 5.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company's stock valued at $313,000 after buying an additional 1,011 shares in the last quarter.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.